Saumya Das MD
Cardiac Electrophysiology, Cardiovascular Disease Genetics
Professor, Harvard Medical School, MGH
Join to View Full Profile
55 Fruit Street Grb 804Massachusetts General HospitalBoston, MA 02114
Phone+1 617-724-0058
Fax+1 617-724-2058
Dr. Das is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 2004 - 2005- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2002
Harvard Medical SchoolClass of 2000
Certifications & Licensure
MA State Medical License 2002 - 2025
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Circulating RNAs in Acute Congestive Heart Failure Start of enrollment: 2016 Aug 17
Publications & Presentations
PubMed
- Self-quenched tRNA reporters for imaging tRNA-derived RNA biogenesis.Guoping Li, Saumya Das
Methods in Enzymology. 2025-01-01 - 1 citationsA prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver.Andrew S Perry, Niran Hadad, Emeli Chatterjee, Maria Jimenez-Ramos, Eric Farber-Eger
Cell Reports. Medicine. 2024-12-17 - 2 citationsA perspective from the National Eye Institute Extracellular Vesicle Workshop: Gaps, needs, and opportunities for studies of extracellular vesicles in vision research.Sun Young Lee, Mikael Klingeborn, Jeff W M Bulte, Daniel T Chiu, Michael Chopp
Journal of Extracellular Vesicles. 2024-12-01
Press Mentions
Proteomic Signature a Key to Early Detection of Fatty Liver Disease: StudyDecember 19th, 2024- Heart Failure Strategically Focused Research Network: Summary of Results and Future DirectionsSeptember 8th, 2022
LQT Therapeutics Announces up to C$1.8M in Seed Funding Led by Fonds De Solidarité FTQ to Accelerate Research of New Therapies for Long QT SyndromeJanuary 8th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
